TrialFrontiers in immunology2025

Antiviral and immunomodulatory effect of zapnometinib in animal models and hospitalized COVID-19 patients.

Yvonne Füll et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.